141 related articles for article (PubMed ID: 27225604)
1. Design and synthesis of N-benzoyl amino acid derivatives as DNA methylation inhibitors.
Garella D; Atlante S; Borretto E; Cocco M; Giorgis M; Costale A; Stevanato L; Miglio G; Cencioni C; Fernández-de Gortari E; Medina-Franco JL; Spallotta F; Gaetano C; Bertinaria M
Chem Biol Drug Des; 2016 Nov; 88(5):664-676. PubMed ID: 27225604
[TBL] [Abstract][Full Text] [Related]
2. Discovery of novel DNA methyltransferase 3A inhibitors via structure-based virtual screening and biological assays.
Shao Z; Xu P; Xu W; Li L; Liu S; Zhang R; Liu YC; Zhang C; Chen S; Luo C
Bioorg Med Chem Lett; 2017 Jan; 27(2):342-346. PubMed ID: 27899265
[TBL] [Abstract][Full Text] [Related]
3. Inhibition studies of DNA methyltransferases by maleimide derivatives of RG108 as non-nucleoside inhibitors.
Rondelet G; Fleury L; Faux C; Masson V; Dubois J; Arimondo PB; Willems L; Wouters J
Future Med Chem; 2017 Sep; 9(13):1465-1481. PubMed ID: 28795598
[TBL] [Abstract][Full Text] [Related]
4. Synthesis of novel 3-halo-3-nitroflavanones and their activities as DNA methyltransferase inhibitors in cancer cells.
Pechalrieu D; Dauzonne D; Arimondo PB; Lopez M
Eur J Med Chem; 2020 Jan; 186():111829. PubMed ID: 31757526
[TBL] [Abstract][Full Text] [Related]
5. Identification of a potential DNA methyltransferase (DNMT) inhibitor.
Jan Z; Ahmed WS; Biswas KH; Jithesh PV
J Biomol Struct Dyn; 2024 Jun; 42(9):4730-4744. PubMed ID: 37424222
[TBL] [Abstract][Full Text] [Related]
6. Design, synthesis and biological evaluation of 4-amino-N- (4-aminophenyl)benzamide analogues of quinoline-based SGI-1027 as inhibitors of DNA methylation.
Rilova E; Erdmann A; Gros C; Masson V; Aussagues Y; Poughon-Cassabois V; Rajavelu A; Jeltsch A; Menon Y; Novosad N; Gregoire JM; Vispé S; Schambel P; Ausseil F; Sautel F; Arimondo PB; Cantagrel F
ChemMedChem; 2014 Mar; 9(3):590-601. PubMed ID: 24678024
[TBL] [Abstract][Full Text] [Related]
7. In silico design of the first DNA-independent mechanism-based inhibitor of mammalian DNA methyltransferase Dnmt1.
Miletić V; Odorčić I; Nikolić P; Svedružić ŽM
PLoS One; 2017; 12(4):e0174410. PubMed ID: 28399172
[TBL] [Abstract][Full Text] [Related]
8. Molecular modeling studies of the novel inhibitors of DNA methyltransferases SGI-1027 and CBC12: implications for the mechanism of inhibition of DNMTs.
Yoo J; Choi S; Medina-Franco JL
PLoS One; 2013; 8(4):e62152. PubMed ID: 23637988
[TBL] [Abstract][Full Text] [Related]
9. Role of protein-protein interactions in allosteric drug design for DNA methyltransferases.
Liang Z; Zhu Y; Liu X; Hu G
Adv Protein Chem Struct Biol; 2020; 121():49-84. PubMed ID: 32312426
[TBL] [Abstract][Full Text] [Related]
10. Rationalization of activity cliffs of a sulfonamide inhibitor of DNA methyltransferases with induced-fit docking.
Medina-Franco JL; Méndez-Lucio O; Yoo J
Int J Mol Sci; 2014 Feb; 15(2):3253-61. PubMed ID: 24566147
[TBL] [Abstract][Full Text] [Related]
11. Identification of kazinol Q, a natural product from Formosan plants, as an inhibitor of DNA methyltransferase.
Weng JR; Lai IL; Yang HC; Lin CN; Bai LY
Phytother Res; 2014 Jan; 28(1):49-54. PubMed ID: 23447335
[TBL] [Abstract][Full Text] [Related]
12. Novel anticancer drug curaxin CBL0137 impairs DNA methylation by eukaryotic DNA methyltransferase Dnmt3a.
Sergeev A; Vorobyov A; Yakubovskaya M; Kirsanova O; Gromova E
Bioorg Med Chem Lett; 2020 Aug; 30(16):127296. PubMed ID: 32631516
[TBL] [Abstract][Full Text] [Related]
13. Trimethylaurintricarboxylic acid inhibits human DNA methyltransferase 1: insights from enzymatic and molecular modeling studies.
Yoo J; Medina-Franco JL
J Mol Model; 2012 Apr; 18(4):1583-9. PubMed ID: 21805123
[TBL] [Abstract][Full Text] [Related]
14. Identifying novel selective non-nucleoside DNA methyltransferase 1 inhibitors through docking-based virtual screening.
Chen S; Wang Y; Zhou W; Li S; Peng J; Shi Z; Hu J; Liu YC; Ding H; Lin Y; Li L; Cheng S; Liu J; Lu T; Jiang H; Liu B; Zheng M; Luo C
J Med Chem; 2014 Nov; 57(21):9028-41. PubMed ID: 25333769
[TBL] [Abstract][Full Text] [Related]
15. Molecular modeling and virtual screening of DNA methyltransferase inhibitors.
Medina-Franco JL; Yoo J
Curr Pharm Des; 2013; 19(12):2138-47. PubMed ID: 23016844
[TBL] [Abstract][Full Text] [Related]
16. Natural products as DNA methyltransferase inhibitors: a computer-aided discovery approach.
Medina-Franco JL; López-Vallejo F; Kuck D; Lyko F
Mol Divers; 2011 May; 15(2):293-304. PubMed ID: 20697809
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis and anticancer potential of NSC-319745 hydroxamic acid derivatives as DNMT and HDAC inhibitors.
Yuan Z; Sun Q; Li D; Miao S; Chen S; Song L; Gao C; Chen Y; Tan C; Jiang Y
Eur J Med Chem; 2017 Jul; 134():281-292. PubMed ID: 28419930
[TBL] [Abstract][Full Text] [Related]
18. Insight into the selective binding mechanism of DNMT1 and DNMT3A inhibitors: a molecular simulation study.
Xie T; Yu J; Fu W; Wang Z; Xu L; Chang S; Wang E; Zhu F; Zeng S; Kang Y; Hou T
Phys Chem Chem Phys; 2019 Jun; 21(24):12931-12947. PubMed ID: 31165133
[TBL] [Abstract][Full Text] [Related]
19. Anticancer drug discovery targeting DNA hypermethylation.
Yu N; Wang M
Curr Med Chem; 2008; 15(14):1350-75. PubMed ID: 18537614
[TBL] [Abstract][Full Text] [Related]
20. Prediction of the binding mechanism of a selective DNA methyltransferase 3A inhibitor by molecular simulation.
Kudo G; Hirao T; Harada R; Hirokawa T; Shigeta Y; Yoshino R
Sci Rep; 2024 Jun; 14(1):13508. PubMed ID: 38866895
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
